Sustained-Release Metformin Research Overview
Glycomet SR 1000 mg is a sustained-release metformin hydrochloride formulation manufactured by USV Private Ltd for laboratory research applications. This pharmaceutical-grade compound represents a biguanide class agent extensively studied for its effects on cellular glucose metabolism, AMP-activated protein kinase (AMPK) activation, and mitochondrial respiratory chain complex I inhibition. The sustained-release formulation provides controlled compound delivery in experimental protocols, making it valuable for researchers investigating metabolic pathways and cellular energy homeostasis mechanisms.
Metformin hydrochloride functions as an antidiabetic biguanide that primarily activates AMPK while inhibiting hepatic gluconeogenesis in research models. Studies demonstrate its ability to enhance insulin sensitivity through multiple molecular pathways, including modulation of fatty acid oxidation and glucose uptake mechanisms. The compound’s effects on cellular metabolism extend beyond glucose regulation, with research indicating potential impacts on autophagy, protein synthesis, and longevity pathways in various experimental systems.
Laboratory Research Applications
Research scientists examining metabolic dysfunction utilise this compound to investigate AMPK-dependent signalling cascades and glucose homeostasis mechanisms. The sustained-release formulation enables extended exposure studies in cellular and tissue models, particularly valuable when examining chronic metabolic adaptations. Investigators studying insulin resistance employ metformin as a reference standard for evaluating novel therapeutic compounds targeting similar pathways.
Cellular biologists research metformin’s effects on mitochondrial function, examining its role in respiratory complex inhibition and subsequent metabolic reprogramming. The compound serves as a tool for studying cellular stress responses, particularly those related to energy deprivation and metabolic adaptation. Researchers at Stroid UK Shop frequently combine metformin studies with SARM research when investigating comprehensive metabolic interventions, while others examine its interaction with peptide modulators in metabolic research protocols. This formulation complements other compounds available in the metformin research category for comprehensive metabolic studies.
Technical Specifications
| Parameter | Specification |
|---|---|
| Active Compound | Metformin Hydrochloride |
| Formulation | Sustained Release |
| Strength | 1000 mg per tablet |
| Manufacturer | USV Private Ltd |
| CAS Number | 1115-70-4 |
| Molecular Formula | C₄H₁₁N₅·HCl |
| Molecular Weight | 165.62 g/mol |
| Storage Conditions | Room temperature, dry environment |
Research Compliance Statement
Glycomet SR 1000 mg is intended exclusively for in-vitro laboratory research applications and scientific investigation. This product is not approved for human consumption, therapeutic use, or any clinical applications. Researchers must ensure compliance with institutional guidelines and applicable regulations when handling this compound. All studies should be conducted by qualified personnel in appropriate laboratory facilities with proper safety protocols and waste disposal procedures.
